Differential effects of chronic antidepressant treatment on swim stress- and fluoxetine-induced secretion of corticosterone and progesterone

Journal of Pharmacology and Experimental Therapeutics

Volumn 285, Issue 2, 1998, Pages 579-587

  Duncan, Gary E ^a   Knapp, Darin J ^a   Carson, Stanley W ^a   Breese, George R ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CORTICOSTERONE; DESIPRAMINE; FLUOXETINE; HYDROCORTISONE; IMIPRAMINE; MONOAMINE OXIDASE INHIBITOR; PHENELZINE; TRANYLCYPROMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CORTICOSTERONE RELEASE; DEPRESSION; DRUG ACTIVITY; HYPOPHYSIS; HYPOPHYSIS ADRENAL SYSTEM; MALE; NONHUMAN; PRIORITY JOURNAL; PROGESTERONE RELEASE; RAT; SWIMMING; TREATMENT PLANNING;

ANIMALS; ANTIDEPRESSIVE AGENTS; CORTICOSTERONE; FLUOXETINE; IMIPRAMINE; MALE; PHENELZINE; PROGESTERONE; RATS; RATS, SPRAGUE-DAWLEY; STRESS; SWIMMING;

EID: 0031808128     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Backstrom T(1995) Symptoms related to the menopause and sex steroid treatments Ciba Found Symp 191:171-180.
2. Baker GB and Greenshaw AJ (1989) Effects of long-term administration of antidepressants and neuroleptics on receptors in the central nervous system. Cell Mol Neurobiol 9:1-44.
3. Banki CM, Bissette G, Arato M, O'Connor L and Nemeroff CB (1987) CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia. Am J Psychiatry 144:873-877.
4. Brady LS, Whitfield, Jr HJ, Fox RJ, Gold PW and Herkenham, M (1991) Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. J Clin Invest 87:831-837.
5. Brady LS, Gold PW, Herkenham M, Lynn AB and Whitfield HJ Jr (1992) The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications. Brain, Res 572:117-125.
6. Breier A and Buchanan RW (1992) The effects of metabolic stress on plasma progesterone in healthy volunteers and schizophrenic patients. Life Sci 51:1527- 1534.
7. Carroll BJ, Feinberg M, Greden JF, Tarika J, Albala AA. Haskett RF, James NM, Kronfol Z, Lohr N, Steiner Mde Vigne JP and Young E (1981) A specific laboratory test for the diagnosis of melancholia: Standardization, validation, and clinical utility. Arch Gen Psychiatry 38:15-22.
8. Crammer JL (1986) Premenstrual depression, cortisol and estradiol treatment. Psychol Med 16:451-455.
9. Deis RP, Leguizamon E and Jahn GA (1989) Feedback regulation by progesterone of stress-induced prolactin release in rats. J Endocrinol 120:37-43.
10. Detke MJ, Rickels M and Lucki I (1995) Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 121:66-72.
11. Duman RS, Heninger GR and Nestler EJ (1994) Adaptations of receptor-coupled signal transduction pathways underlying stress- and drug-induced neural plasticity. J Nerv Ment Dis 182:692-700.
12. Duncan GE, Knapp DJ, Johnson KB and Breese GR (1996) Functional Classification of antidepressants based upon antagonism of swim stress-induced Fos-like immunoreaetivity. J Pharmacol Exp Ther 277:1076-1089.
13. Duncan GE, Paul IA, Harden JK, Mueller RA, Stumpf W and Breese GR (1985) Rapid down regulation of β-adrenergic receptors by combining antidepressant drugs with forced swim: A model of antidepreasant-induced neural adaptation. J Pharmacol Exp Ther 234:402-408.
14. Ettigi PG and Brown GM (1977) Psychoneuroendocrinology of affective disorders: An overview. Am J Psychiatry 134:493-501.
15. Fuller RW and Snoddy HD (1990) Serotonin receptor subtypes involved in the elevation of serum corticosterone concentration in rats by direct- and indirect- aging serotonin agoniats. Neuroendocrinology 52:206-211.
16. Fuller RW, Snoddy HD and Molloy BB (1986) Central serotonin agonist actions of LY 165163, 1-(m-trifluoromethylpheny)-4(p-aminophenylethyl)-piperazine, in rats. J Pharmacol Exp Ther 239:454-459.
17. Ganong WF and Forsham PH (1960) Adenohypophysis and adrenal cortex. Annu Rev Physiol 22:579-614.
18. Gibbons JL (1964) Cortisol secretion rate in depressive illness. Arch Gen Psychiatry 10:572-575.
19. Heninger GR and Charney DS (1987) Mechanisms of action of antidepresaant treatments: implications for the etiology and treatment of depressive disorders, in Psychopharmacology: The Third Generation of Progress (Meltzer HY, ed) pp 535- 544, Raven, New York.
20. Herman JP and Cullinan WE (1997) Neurocircuitry of stress: Central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci 20:78-84.
21. Holsboer F and Barden N (1996) Antidepressants and hypothalamic-pituitary- adrenocortical regulation. Endocr Rev 17:187-205.
22. Holsboer F, von Bardeleben U, Wiedemann K, Muller OA and Stalla GK (1987) Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression-Implications for pathophysiology of DST non-suppression. Biol Psychiatry 22:228-234.
23. Johnson AM (1991) The comparative pharmacological properties of selective serotonin re-uptake inhibitors in animals, in Perspectives in Psychiatry, vol 1: Selective Serotonin Re-uptake Inhibitors (Feighner JP and Boyer WF, eds) pp 37-70, John Wiley and Sons, New York.
24. Katz MM, Koslow SH, Maas J, Frazer A, Secunda S, Bowden CL, Casper RC, Croughan J, Kocsis J and Redmond E (1987) The timing, specificity, and clinical prediction of tricyclic drug effects in depression. Psychol Med 17:297-309.
25. Klein DF and Davis JM (1969) Diagnosis and Drug Treatment in Psychiatric Disorders. Williams & Wilkins Co., Baltimore.
26. Koenig JI, Gudelsky GA and Meltzer HY (1987) Stimulation of corticosterone and β-endorphin secretion in the rat by selective 5-HT receptor subtype activation. Eur J Pharmacol 45:305-310.
27. Li Q, Levy AD, Cabrere TM, Brownfield MS, Battaglia G and Van de Kar LD (1993) Long-term fluoxetine, but not desipramine, inhibits the ACTH and oxytocin responses to the 5-HT1A agonist, 8-OH-DPAT, in male rats. Brain Res 630:148-156.
28. Li Q, Brownfield MS, Levy AD, Battaglia G, Cabrera TM and Van de Kar LD (1994) Attenuation of hormone responses to the 5-HT1A agonist isapirone by long-term treatment with fluoxetine, but not desipramine, in male rats. Biol Psychiatry 36:300-308.
29. Linkowski P, Mendlewicz J, Kerkhofs M, Leclercq R, Goldstein J, Brasseur M, Copinschi G and Van Cauter E (1987) 24-hour profiles of adrenocorticotropin, cortisol, and growth hormone in major depressive illness: Effect of antidepressant treatment. J Clin Endocrinol Metab 65:141-152.
30. Majewska MD. Harrison NL, Schwartz RD, Barker JL and Paul SM (1986) Steroid hormone metabolites and barbiturate-like modulators of the GABA receptor. Science 232:1004-1007.
31. Meikle AW and Tyler FH (1977) Potency and duration of action of glucocorticoids. Am J Med 83:200-207.
32. Morrow AL, Suzdak PD and Paul SM (1987) Steroid hormone metabolites potentate GABA receptor-mediated chloride ion flux with nanomolar potency. Eur J Pharmacol 142:483-485.
33. Nemeroff CB, Widerlow E, Bissette G, Walleus H, Karlsson I, Eklund K, Klits CD, Loosen PT and Vale W (1984) Elevated concentrations of CSF corticotropin- releasing actor-like immunoreactivity in depressed patients. Science 226:1342- 1344.
34. Nequin LG, Alvarez JA and Campbell CS (1975) Alterations in steroid and gonadotropin release resulting from surgical stress during the morning of proestrus in 5-day cyclic rats. Endocrinology 97:718-724.
35. Paul SM and Purdy RH (1992) Neuroactive steroids. FASEB J 6:2311-2322.
36. Porsolt RD, Anton A, Blavet N and Jalfre M (1978) Behavioral despair in rats: A new model sensitive to anlidepressant treatments. Eur J Pharmacol 47:379-391.
37. Purdy RH, Morrow AL, Moore PH, Jr and Paul SM (1991) Stress-induced elevations of γ-aminobutyric acid type A receptor-active steroids in the rat brain. Proc Natl Acad Sci USA 88:4553-4557.
38. Raadsheer FC, van Heerikhuize JJ, Lucassen PJ, Hoogendijk WJG, Tilders FJH and Swaab DF (1995) Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. Am J Psychiatry 152:1372-1376.
39. Randrup A and Braestrup C (1977) Uptake inhibition of biogenic amines by newer antidepresaant drugs. Relevance to the dopamine hypothesis of depression. Psychopharmacology 52:308-314.
40. Reul JMHM, Stec I, Sodr M and Holsboer F (1993) Chronic treatment of rats with the antidepressant amytriptyline attenuates the activity of the hypothalamic- pituitary-adrenocortical system. Endocrinology 133:312-320.
41. Rubin RT, Poland RE, Lesser IM, Winston RA and Boldgett ALN (1987) Neuroendocrine aspects of primary endogenous depression. Arch Gen Psychiatry 44:238- 336.
42. Rutter JJ, Gundlah C and Auerbach SB (1994) Increase in extracellular serotonin produced by uptake inhibitors is enhanced after chronic fluoxetine treatment. Neurosci Lett 171:183-186.
43. Sachar EJ (1975) Neuroendocrine abnormalities in depressive illness, in Topics in Psychoendocrinology (Sachar EJ, ed) pp 256-298, Grune and Stratton, New York.
44. Sawchenko PE (1990) The final common path: Issues concerning the organization of central mechanisms controlling corticotropin secretion, in Stress Neurobiology and Neuroendocrinology (Brown MR, Koob GF and Rivier C, eds) pp 55-71. New York: Marcel Dekker, publisher.
45. Schaeffer C and Aron CL (1987) Stress-related effects on the secretion of progesterone by the adrenals in castrated male rats presented to stimulus males. Involvement of estrogen. Acta Endocrinol 114:440-445.
46. Schmider J, Lammers, C-H, Gotthardt U, Dettling M, Holsboer F and Heuser IJE (1995) Combined dexamethasone/corticotropin releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls. Biol Psychiatry 38:792-802.
47. 7 receptor binding sites in rat hypothalamus: Sensitivity to chronic antidepressant treatment. Mol Pharmacol 47:99-103.
48. Souetre E, Salvati E, Belugou JL, Pringuey D, Candito M, Krebbs B, Ardisson JL and Darcourt G (1989) Circadian rhythms in depression and recovery: Evidence for blunted amplitude as the main chronobiological abnormality. Psychiatry Res 28: 263-278.
49. Stark P, Fuller RW and Wong DT (1985) The pharmacologic profile of fluoxetine. J Clin Psychiatry 46:7-13.
50. Steiger A, Von Bardelebon V, Herth T and Holsboer F (1989) Sleep electroencephalogram and nocturnal secretion of cortisol and growth hormone in male patients with endogenous depression before treatment and after recovery. J Affect Dis 16:189-195.
51. Stokes PE, Pick GR, Stoll PM and Nunn WD (1975) Pituitary-adrenal function in depressed patients: Resistance to dexamethasone suppression. J Psychiatr Res 12:271-281.
52. 7 receptors in guinea-pig brain. Br J Pharmacol 115:107-116.
53. Urban JH, Van de Kar LD, Lorens SA and Bethea CL (1986) Effect of the anxiolytic drug buspirone on prolactin and corticosterone secretion in stressed and unstressed rats. Pharmacol Biochem Behav 25:457-462.
54. Wagner KD and Berenson AB (1994) Norplant-associated major depression and panic disorder. J Clin Psychiatry 55:478-480.
55. 3H- imipramine binding site. Neuropharmacology 25:519-525.